Javier M. B.
- Country
- Spain
- Department
- Medical Oncology
Research Overview
- (Peak) A Phase 3 Randomized, Open-label, Multicenter Clinical Study of CGT9486+Sunitinib vs Sunitinib in Subjects with Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
- Phase 3 Randomized Double-Blind Placebo-Controlled Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor
- Phase I/II Randomized Study of LB-100 and Doxorubicin Versus Doxorubicin Monotherapy in Advanced Soft Tissue Sarcomas
Data & Insights
Has run more than one trial at 53 of 126 partner sites.
Specializations
Oncology Focus
This investigator specializes in the study and treatment of Tenosynovial Giant Cell Tumor (TGCT), a rare condition affecting the synovial tissue of joints, bursae, and tendon sheaths.
- Tumor Response Assessment
- Joint-Related Tumors
- Rare Tumor Management
The investigator's work encompasses evaluation of novel therapeutic approaches for TGCT patients.
Clinical Assessment
Expertise in measuring objective response rates and implementing standardized evaluation criteria in tumor assessment protocols.
- Treatment Response Monitoring
- Clinical Outcomes Measurement
- Patient Response Evaluation
The investigator utilizes systematic approaches to evaluate therapeutic effectiveness in clinical settings.
Therapeutic Development
Focus on investigating novel therapeutic agents for the treatment of rare musculoskeletal tumors.
- Targeted Therapy Research
- Safety Assessment
- Antitumor Activity Evaluation
The investigator's research includes assessment of innovative treatment approaches for rare tumor conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.